Building Enduring Businesses in
Pharma Services

We partner with technology-enabled, EBITDA-positive pharma services businesses driving innovation in manufacturing and clinical trial services

Investment Themes

Outsourced Complex Biomanufacturing

Our companies manufacture and support the supply chain for complex medicines—including biologics, bioconjugates, cell therapies, and peptides—delivering science, scale, and quality to the life sciences industry and patients.

HOME-Abzena

Outsourced Biologics Manufacturing

Kin_logo

Outsourced Cell Therapy Manufacturing

Outsourced Clinical Trial Services

We back companies modernizing the clinical trials workflow through improved site operations, smarter patient recruitment, increased participant access, and purpose-built technology. 

cedar_logo

Clinical Trial Site Network

Cenexel 3

Clinical Trial Site Network

HOME-Path AI

Digitized Pathology Platform for Clinical Trials

Digital Transformation

Lab Procurement Platform and Marketplace for R&D

Direct-to-Patient Platform for Clinical Trials

News & Insights

Latest activity from Biospring and our portfolio

August 07, 2025

Biospring Backs CenExel; PathAI Expands Offering Post FDA Approval

April 14, 2025

Biospring Interview with Britt Harris (UTIMCO)

April 11, 2024

Primer: Radiopharma Overview